Computational journey to unveil organophosphorothioate pesticides' metabolism: A focus on chlorpyrifos and CYP2C19 mutational landscape

被引:0
|
作者
Pedroni, Lorenzo
Perugino, Florinda [1 ]
Dall'Asta, Chiara
Galaverna, Gianni
Buratti, Franca Maria
Testai, Emanuela
Dellafiora, Luca [1 ]
机构
[1] Univ Parma, Dept Food & Drug, Parco Area Sci 27-A, I-43124 Parma, Italy
关键词
Molecular modelling; Pesticides; Chlorpyrifos; Cytochrome P450; Polymorphisms; CYTOCHROME-P450; STRUCTURE; FORCE-FIELD; DYNAMICS; SUBSTRATE; INSIGHTS; BINDING; MEPHENYTOIN; EXPOSURE; PROBE; MODE;
D O I
10.1016/j.ecoenv.2024.117354
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Organophosphorothioates (OPT) are pesticides impacting human, animal and environmental health. They enter the environment worldwide, primarily due to their application as insecticides. OPTs are mainly neurotoxic upon bioactivation and inhibition of brain and serum acetylcholinesterase (AChE). Although OPTs are meant to target insects, they are potentially toxic to many other species (including humans), posing risks to non-target organisms and ecosystems. Certain cytochromes P450 (CYP) promote OPTs bioactivation, forming the corresponding oxon metabolites, while others catalyse their detoxification. Understanding the molecular basis of such a bivalent fate may help to clarify the toxicity of OPTs in living organisms, with far-reaching consequences to understand their impact on living organisms and improve risk assessment, to cite but a few. However, although crucial, the underpinning mechanisms still lay unclear. Here, a validated computational pipeline revealed the molecular reasons underlying the differential metabolism of chlorpyrifos in humans by CYP2C19, a primal route of detoxification, and its bioactivation by CYP2B6. The analysis drew the diverse occupancy of the CYP pocket and orientation to the heme group as a convincing evidence-based explanation for the opposite transformation. Moreover, this study explored the impact of CYP2C19 mutational landscape giving a blueprint to unveil the molecular basis of OPTs metabolism and toxicological implications from an inter-individual perspective. Taken together, the outcome described for the first time to the best of our knowledge a structural rationale for the bioactivation/detoxification of OPTs improving the current understanding of their toxicity from a molecular standpoint.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Molecular modelling study on CYP2C19 mediated biotransformation of organophosphorothioate pesticides: insights on a possible mutational landscape
    Pedroni, L.
    Perugino, F.
    Dall'Asta, C.
    Galaverna, G.
    Buratti, F. M.
    Testai, E.
    Dellafiora, L.
    TOXICOLOGY LETTERS, 2024, 399 : S145 - S145
  • [2] Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism
    Crane, Alice L.
    Klein, Kathrin
    Zanger, Ulrich M.
    Olson, James R.
    TOXICOLOGY, 2012, 293 (1-3) : 115 - 122
  • [3] CYP2C19 genotype and the PPIs - focus on rabeprazole
    Lim, PWY
    Goh, KL
    Wong, BCY
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 : S22 - S28
  • [4] The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway
    Ford, Neville F.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (12): : 1474 - 1483
  • [6] Human CYP2C19 Substrate and Inhibitor Characterization of Organophosphate Pesticides
    Vignaux, Patricia A.
    Shriwas, Pratik
    Revnew, Andre
    Agarwal, Garima
    Lane, Thomas R.
    Mcelroy, Craig A.
    Ekins, Sean
    CHEMICAL RESEARCH IN TOXICOLOGY, 2023, 36 (09) : 1451 - 1455
  • [7] Influence of azimilide on CYP2C19 mediated metabolism.
    El Mouelhi, M
    Thompson, GA
    Worley, DJ
    Kuzmak, B
    Destefano, AJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P32 - P32
  • [8] CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline
    Laine, K
    Anttila, M
    Nyman, L
    Wahlberg, A
    Bertilsson, L
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (02) : 137 - 142
  • [9] Effects of CYP2C19 Variants on Fluoxetine Metabolism in vitro
    Fang, Ping
    He, Jia-Yang
    Han, Ai-Xia
    Lan, Tian
    Dai, Da-Peng
    Cai, Jian-Ping
    Hu, Guo-Xin
    PHARMACOLOGY, 2017, 100 (1-2) : 91 - 97
  • [10] EFFECT OF OBESITY ON CYP2C19 METABOLISM IN CHILDREN.
    Shakhnovich, V.
    Abdel-Rahman, S.
    Friesen, C.
    Pearce, R.
    Gaedigk, A.
    Leeder, J.
    Kearns, G. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S19 - S20